The Institute for Health Policy Accountability (IHPA), an independent authority on key drivers of decision-making in the healthcare space, today released a new report in a series exposing how billionaire John Arnold and his organization, Arnold Ventures, are spending tens of millions of dollars to undermine President Trump’s policy agenda, directly contradicting the group’s claim of having a goal to advance bipartisan causes. 

Arnold Ventures has been particularly active in the health care arena in recent years, but its hidden agenda on a number of key issues has received little scrutiny.

The new research details how, across major policy areas, Arnold Ventures has bankrolled left-leaning think tanks and advocacy groups who actively work to stop President Trump’s America First agenda, from cutting taxes for working families to securing the border. 

Key findings from the IHPA research include:

Opposing President Trump’s Tax Cuts

President Trump’s One Big Beautiful Bill delivered the largest nominal tax cut in American history, providing the average household with a $2,100 tax cut in 2026. John Arnold has called the bill “catastrophic” and funded its chief critics:

• The Brookings Institution, which has received more than $5.7 million from the Laura and John Arnold Foundation since 2020, warned Americans not to “expect much growth” from the bill and attacked the White House’s own economic analysis.
• The Center on Budget and Policy Priorities (CBPP), which has received over $1.5 million from Arnold since 2020, branded the bill the “harmful Republican Megabill” and claimed it takes “food from needy families to pay the wealthy.”

Opposing President Trump’s Energy Agenda

President Trump’s pro-energy executive orders and the EPA’s rescission of the 2009 carbon endangerment finding are projected to save U.S. consumers over $1 trillion in automobile costs. Arnold-backed organizations fought every step of the way:

• CBPP openly opposed Trump’s energy executive order and urged Democrats to “protect against any such cuts or unlawful impoundment of funds.”
• The Center for American Progress (CAP), which received over $1.5 million from Arnold since 2020, actively recruited states to defy the Trump administration and preserve Biden-era climate policies.

Opposing Border Security and Immigration Enforcement

President Trump’s border agenda has achieved a full year with zero illegal entrants released, reversing the record 68,000 illegal alien releases in a single month under President Biden. Arnold’s network has funded efforts to stop deportations:

• The Vera Institute of Justice, which received $13.97 million from the Laura and John Arnold Foundation since 2020, published a roadmap on “how to fight Trump’s mass deportation agenda” and launched a public defender network for illegal immigrants facing deportation.
• The Urban Institute, which received more than $34.1 million from Arnold since 2020, produced research designed to portray immigration enforcement as harmful to children.

Opposing President Trump’s Action to Stop a Nuclear Iran

Following Operation Epic Fury, which aimed to destroy Iran’s nuclear weapons capability, Arnold personally cast doubt on the President’s military leadership and funded organizations declaring the operation unconstitutional:

• CAP called President Trump’s confrontation of Iran “unconstitutional on multiple fronts” and claimed it would be remembered as “a reckless war of choice.”
• Brookings scholar Robert Kagan penned a piece in The Atlantic declaring that President Trump had lost the war.

Opposing President Trump’s Trade Agenda

Through tariffs and trade negotiations, President Trump has leveraged $10.6 trillion in foreign investment. Arnold-backed groups have worked to reverse these gains:

• The Urban Institute called Trump’s tariffs “economically destructive” and suggested they could cause democracy to suffer.
• CBPP claimed Trump’s tariffs and OBBB combined “would leave the bottom 70% of households worse off.”

Read the full report here.

Arnold Ventures was founded by billionaires Laura and John Arnold, who have cultivated an image of bipartisanship, particularly in healthcare policy. The Laura and John Arnold Foundation serves as the philanthropic arm of Arnold Ventures and commands $4.77 billion in assets with approximately $200 million in annual spending. Despite publicly emphasizing across-the-aisle collaboration, Arnold Ventures has directed substantial funding to organizations that have made opposing President Trump a central focus of their advocacy and research.

The Institute for Health Policy Accountability is an independent authority on key drivers of decision making in the health care space. IHPA provides fact-based research and analysis across the public policy landscape, adding a central and currently missing voice to the conversation.

###

The post IHPA Report Exposes How So-Called “Bipartisan” Billionaire John Arnold Spends Millions Fighting President Trump’s Policy Agenda appeared first on Institute for Health Policy Accountability.

Earlier this week, the CEOs of several large non-profit hospital systems went before the House Ways & Means Committee for a hearing examining how hospitals are driving up healthcare costs for patients. The CEOs of these systems, New York-Presbyterian Hospital, CommonSpirit Hospital, and ECU Health, all blamed labor costs, pharmaceutical prices, administrative costs, and regulatory burdens for driving the costs of healthcare. 

However, these executives should also look no further than their own compensation, perks, and abuse of the 340B program to explain how they are hurting patients. Not only are these “non-profit” hospitals lining their own pockets with huge salaries, they are profiting from a federal program that was meant to serve “safety net” hospitals and low-income patients. 

Chairman Jason Smith (R-MO) even stated during his opening remarks: “Large hospital systems…manipulate the 340B drug pricing program to keep steep drug discounts for themselves instead of passing the savings to low-income patients. There is little evidence that the $290 billion in discounts given to hospitals under the 340B program since Obamacare was ever reinvested in patients. Even worse, there is evidence that hospital abuse of 340B actually directly led to increases in Obamacare premiums.”

Below is a quick look at just how much money these hospitals are making while taking advantage of the “safety net” federal program meant for low income patients. These hospitals are pocketing big profits and giving their CEOs big payouts. 

New York-Presbyterian Hospital

New York-Presbyterian is New York’s highest-operating-expense 340B hospital, but provides just 0.97% of its operating costs to charity care. In 2024, the hospital reported $10.7 billion revenue and nearly $22 billion assets. Additionally, during the hearing, New York-Presbyterian was questioned regarding a recent suit brought by the U.S. Department of Justice alleging anticompetitive contacts, which they denied. Chairman Smith also questioned why New York-Presbyterian is designated a rural referral center, giving them “easier access to heavily discounted drugs under the 340B program” and giving them a “windfall of benefits intended to support truly rural hospitals.”

It spent nearly $24 million on “conflict of interest” transactions, including salaries for family members of key employees and officers, and lease payments and legal fees to trustees with interest in those respective organizations. They also paid for first-class travel, housing allowances, and personal services (i.e. maids, chauffeur, chefs) for some of their executives.

Brian Donley, the President and CEO, reported over $5 million in compensation from the organization as an executive vice president and chief operating officer in 2024. His current compensation since taking over as CEO six months ago has not been reported yet, but is likely to be even higher.

Meanwhile, hospital revenue from pharmacy sales skyrocketed from $25 million to $93 million from 2021 to 2022, and increased 880% over five years (2019-2024).

During the hearing, members of Congress noted that one of the organization’s hospitals gives Chanel goody bags to new moms, while reportedly charging around $35,000 to give birth there.

CommonSpirit Health

CommonSpirit says that “over 115 CommonSpirit Health hospitals, clinics, and infusion centers participate in the 340B Program, from rural community hospitals in the Midwest to large urban safety-net hospitals on the West Coast.” 

In 2024, President and CEO Wright Lassiter received over $15 million in compensation from CommonSpirit and related organizations, which was questioned during the hearing. Representative Lloyd Smucker (R-PA) asked Mr. Lassiter during the hearing about excessive spending on board meetings abroad, citing the organization’s own 990. In the same year, CommonSpirit paid over $200,000 to E-Lead Resources, Inc, a promotional products and marketing company owned by a family member of one of their former officers. CommonSpirit reported over $3.4 billion in revenue and nearly $10 billion in assets in 2024, and provided first-class or charter travel to its executives, even though they ultimately reported a loss of over $271 million.

ECU Health

ECU Health is no stranger to increasing the costs of health care services. ECU Health is also familiar with raking in big profits. In 2023, the “non-profit” health system reported nearly $440 million in revenue and paid $10.5 million in executive compensation. ECU’s CEO Michael Waldrum reported over $1.7 million in total compensation in 2023 according to the organization’s latest 990. 

ECU has also been accused of deceptive billing and debt collection practices, while they rake in millions in revenue. In 2022, a patient filed suit against ECU, alleging that they charged patients with private insurance “undisclosed” and “unreasonably high” prices, potentially higher than “ten times” the Medicare rate. The suit also cited “aggressive debt collection practices” that left them no choice but to pay these absurdly high rates for care.

Meanwhile, ECU’s patient care leaves something to be desired. Last year, ECU paid nearly $120,000 to the Department of Health and Human Services after failing “to provide an appropriate medical screening examination to a patient.” After failing to determine whether the patient, who had a medical history of dementia, was competent to leave the facility, they allowed him to leave without notifying family or the assisted living facility he resided in, and unfortunately, was later found dead. 

The post Congress Questions Big Salaries at “Non-Profit” Hospitals as Healthcare Costs Soar appeared first on Institute for Health Policy Accountability.

The Institute for Health Policy Accountability (IHPA), an independent authority on key drivers of decision-making in the health care space, today released a sweeping new report exposing how Ohio’s “non-profit” health centers are suing vulnerable patients for unpaid bills, handing executives outsized compensation packages, and failing federal compliance standards, all while collecting taxpayer-funded benefits through the 340B federal drug discount program. And now, state lawmakers are considering legislation that would give these same health centers even more.

The Ohio Statehouse is currently considering HB 276 / SB198, which would bar drug manufacturers from restricting 340B drug shipments to health centers and contract pharmacies, stripping away existing guardrails and opening the door to even greater abuse of a program designed to serve vulnerable communities. The health centers cheering on this legislation are the same ones this report catches red-handed, pocketing millions in drug markups, and shortchanging low-income patients. 

The Ohio report continues IHPA’s ongoing series revealing how non-profit health centers across the country exploit the 340B program while failing the communities they are meant to serve. The report examines several Ohio non-profit health centers participating in the 340B program: Signature Health, Five Rivers Health Centers, HealthSource of Ohio, Highland Health Providers, Mary Rutan Health, MetroHealth Medical Center, Mount Carmel Health System, Northeast Ohio Neighborhood Health Services, Health Partners of Western Ohio, and Third Street Clinics.

Key findings from the IHPA Ohio report include:

Drug pricing abuse and explosive pharmacy revenue growth

• Health Partners of Western Ohio reported over $30.2 million in 340B pharmacy revenue in 2024, representing more than 40% of its total revenue.
• Five Rivers Health Centers made nearly $23 million in pharmacy revenue while spending just $9 million on medication supply costs, a markup of more than 150%, and a dramatic increase from just $4.6 million in pharmacy revenue in 2020. Five Rivers also spent nearly 3.5% of its expenses on executive compensation in 2024.
• Third Street Clinics saw pharmacy revenue surge from $3.9 million in 2023 to $10.5 million in 2024, while the average markup on prescription drugs nearly doubled.
• Highland Health Providers posted a 270% increase in pharmacy revenue in its first year working with a 340B compliance consultant, with prescription capacity growing 560% and its claims capture rate doubling from 2023 to 2024. 

Suing vulnerable patients and cutting charity care

• Mary Rutan Health sued 2,700 patients over two years for unpaid medical bills. 
• Mount Carmel Health System sued 1,600 patients over two years for unpaid medical bills, despite many being at 100 percent of the poverty level.

Read the full report here.

BACKGROUND ON 340B: 

• The 340B Drug Pricing Program was enacted by Congress in 1992 and meant to lower prescription drug costs for non-profit hospitals that serve low-income and vulnerable communities. Instead, research shows the program has been exploited by major non-profit health systems that generate billions in annual revenue.
• This report follows a Senate HELP Committee hearing in October 2025, where Republican Senators voiced their frustrations with the program.
• According to a CBO analysis late last year, hospitals across the U.S. have exploited the 340B Drug Pricing Program, resulting in significant waste, fraud, and abuse. The report found that the program “encourages behaviors that increase federal spending and raise prices for American taxpayers.”

The Institute for Health Policy Accountability is an independent authority on key drivers of decision making in the health care space. IHPA provides fact-based research and analysis across the public policy landscape, adding a central and currently missing voice to the conversation.

###

The post IHPA Report: As Ohio Considers Legislation to Expand 340B Loopholes, “Non-Profit” Health Centers Pocket Millions and Leave Low-Income Patients Behind appeared first on Institute for Health Policy Accountability.

The new research details how Arnold Ventures publicly claims to “work across the political spectrum to build durable, bipartisan coalitions,” while its funding tells an entirely different story. Since 2020, the Laura and John Arnold Foundation has directed nearly $10 million to Washington, D.C.-based think tanks and advocacy groups that have consistently pushed to expand federal and state health benefits to illegal immigrants, the same policies Congressional Democrats were willing to shut down the federal government for 43 days to protect.

Key findings from the IHPA research include:

• Center on Budget and Policy Priorities: Arnold has provided more than $2 million in funding since 2020.
  • CBPP authored a report arguing that an “inclusive approach to immigrants who are undocumented can help families and states prosper,” explicitly calling for expanded health coverage to undocumented children as “a strong first step towards access to health care coverage for all.”
  • The organization has criticized President Trump’s immigration enforcement since his first term, describing his administration’s actions as having “created a climate of fear” among undocumented immigrant families.
• Brookings Institution: Arnold has provided more than $5.7 million in funding since 2020
  • Brookings proposed expanding federally funded community health centers to provide primary care to illegal immigrants and explicitly called for expanding Medicaid eligibility to undocumented immigrants as part of COVID-19 legislation.
• National Partnership for Women and Families: Arnold has provided $643,583 in funding since 2020
  • NPWF called on Congress to pass the HEAL Act to ensure “all immigrants, regardless of status, have access to public and affordable health coverage.”
• Center for American Progress: Arnold has provided more than $1.5 million in funding since 2020
  • CAP proposed multiple workarounds to extend public health coverage to the undocumented population, including granting citizenship to 11 million illegal immigrants.
• PrEP4All: Arnold has provided nearly $120,000 in funding since 2020
  • PrEP4All released a 2024 plan for a federally funded national PrEP program explicitly designed to provide free HIV medication to illegal immigrants through a “PrEP Pass” requiring minimal paperwork and no financial eligibility verification.

Read the full report here.

The Institute for Health Policy Accountability is an independent authority on key drivers of decision making in the health care space. IHPA provides fact-based research and analysis across the public policy landscape, adding a central and currently missing voice to the conversation.

###

The post IHPA Report Finds “Bipartisan” Arnold Ventures Quietly Bankrolls Groups Pushing For Taxpayer-Funded Healthcare for Illegal Immigrants appeared first on Institute for Health Policy Accountability.

The Institute for Health Policy Accountability (IHPA), an independent authority on key drivers of decision-making in the health care space, today released a sweeping new report exposing how Michigan’s largest “non-profit” hospital systems are sitting on billions in revenue and handing their executives multimillion-dollar compensation packages while sidelining their low-income patients.

The Michigan report continues IHPA’s series, revealing how powerful hospitals profit from the 340B federal drug discount program while putting low-income patients last. The report examines nine major Michigan hospital systems participating in the 340B program: Corewell Health, Henry Ford Health System, Trinity Health Michigan, Bronson Methodist Hospital, Edward W. Sparrow Hospital Association, Allegiance Health, Covenant Healthcare System, University of Michigan Health-West, and Munson Healthcare.

Key findings from the IHPA Michigan report include:

Failure to serve low-income communities

• An analysis of every Michigan non-profit hospital from 2020 to 2022 found that 75% had a fair share deficit, meaning they receive more in tax benefits than they provide in community benefits, totaling $605 million per year.
• Michigan hospitals participating in the 340B program report nearly 50% higher patient revenue than comparable hospitals while providing 30% less charity care.
• University of Michigan Health-West had the largest fair share deficit of any non-profit hospital in the state, averaging $76 million per year between 2020 and 2022.

Lavish executive compensation and corporate excess

• Corewell Health’s president made nearly $5.5 million in compensation in 2024, with total executive compensation exceeding $30.1 million.
• Henry Ford Health’s President and CEO made over $7 million in 2024, with 16 other employees clearing seven figures. Henry Ford’s total executive compensation exceeded $27 million.

Massive revenues and rapid financial growth

• Corewell Health reported $11.5 billion in annual revenue in 2024, a $1.1 billion year-over-year increase of 10.7%.
• Henry Ford Health System generated $5.28 billion in revenue, growing 17.5% year over year, and partnered on a $2.5 billion construction investment that includes housing units and a deal with the Detroit Pistons professional basketball team.
• Trinity Health Michigan brought in $3.28 billion in annual revenue.

Fraud, abuse, and putting profits over patients

• Covenant Healthcare System paid $69 million in 2023 to resolve allegations of improper financial relationships that led to false claims submitted to Medicare, Medicaid, TRICARE, and FECA programs.
• Edward W. Sparrow Hospital Association paid nearly $700,000 to settle claims it violated the False Claims Act through improper Medicare billing, with the U.S. Department of Justice noting the behavior “wastes valuable taxpayer funds set aside to care for the well-being of those most in need.”

Read the full report here.

BACKGROUND ON 340B: 

• The 340B Drug Pricing Program was enacted by Congress in 1992 and meant to lower prescription drug costs for non-profit hospitals that serve low-income and vulnerable communities. Instead, research shows the program has been exploited by major non-profit health systems that generate billions in annual revenue.
• This report follows a Senate HELP Committee hearing in October 2025, where Republican Senators voiced their frustrations with the program.
• According to a CBO analysis late last year, hospitals across the U.S. have exploited the 340B Drug Pricing Program, resulting in significant waste, fraud, and abuse. The report found that the program “encourages behaviors that increase federal spending and raise prices for American taxpayers.”

The Institute for Health Policy Accountability is an independent authority on key drivers of decision making in the health care space. IHPA provides fact-based research and analysis across the public policy landscape, adding a central and currently missing voice to the conversation.

###

The post IHPA Report: Michigan’s Wealthiest “Non-Profit” Hospitals Are Pocketing Billions While Gaming a Program Built for Low-Income Patients appeared first on Institute for Health Policy Accountability.

The Institute for Health Policy Accountability (IHPA), an independent authority on key drivers of decision-making in the health care space, today released its second report in a series exposing the anti-Trump sentiments held by the founders and senior executives of Arnold Ventures. The self-described “bipartisan” philanthropy is led by John Arnold and his wife, Laura Arnold. Far from the across-the-aisle operation it claims to be, Arnold Ventures has been home to leaders who sought to delegitimize President Trump, undermine his electoral prospects, and dismiss his policy accomplishments as empty politics.

Key findings from the IHPA research include:

John Arnold

• Arnold Ventures founder John Arnold publicly endorsed Twitter’s decision to ban President Trump from the platform, calling it “weird and scary and soothing and consequential and also feels correct.”
• John Arnold seemingly advocated for barring President Trump from running for office again, stating: “There will be 4 years of chaos and infighting in the Republican Party if Trump is not prohibited from running again. McConnell knows this.”
• Arnold called President Trump less “of a distraction if the party doesn’t have to worry about him running again.”
• On the One Big Beautiful Bill (OBBB), Laura and John Arnold called it “catastrophic,” with John Arnold claiming it was “crammed through” on an “artificial timeline” and enacted “for no good reason besides that it’s politically popular and helps one get reelected.”

Sam Mar

• Arnold Ventures’ former Vice President Sam Mar authored a scathing op-ed after January 6, 2021, calling the events an “insurrection,” a “dark day in our nation’s democracy,” and a “symptom of a deeper disease infecting our nation.” The op-ed was featured on Arnold Ventures’ website before being quietly scrubbed earlier this year.
• Mar accused President Trump and his supporters of dealing in “fake news and conspiracy theories” and blamed them for reflecting a political system “that actually encourages this type of hatred and violence.”

Read the full report here.

Arnold Ventures was founded by billionaires Laura and John Arnold, who have cultivated an image of bipartisanship, particularly in healthcare policy. The Laura and John Arnold Foundation serves as the philanthropic arm of Arnold Ventures and commands $4.77 billion in assets with approximately $200 million in annual spending. Despite publicly emphasizing across-the-aisle collaboration, Arnold Ventures has directed substantial funding to organizations that have made opposing President Trump a central focus of their advocacy and research. 

The Institute for Health Policy Accountability is an independent authority on key drivers of decision making in the health care space. IHPA provides fact-based research and analysis across the public policy landscape, adding a central and currently missing voice to the conversation.

###

The post IHPA Report Finds “Bipartisan” Arnold Ventures Founders and Executives Openly Questioned President Trump’s Motives and Sought to Undermine His Agenda appeared first on Institute for Health Policy Accountability.

With $4.77 billion in assets and approximately $200 million in annual spending, the Laura and John Arnold Foundation has bankrolled left-leaning organizations that actively oppose President Trump and his administration, raising questions about the disconnect between the organization’s stated bipartisan mission and its funding priorities.

Key findings from the IHPA research include:

• RAND Corporation: Arnold has provided $12.76 million in funding since 2020
  • RAND scholars have compared President Trump to authoritarian leaders in El Salvador, Tunisia, Peru, and Pakistan.
  • RAND political scientist Alexander Noyes described January 6th as a “failed executive coup” aimed at perpetuating Trump’s “hold on power after losing at the ballot box.”
  • RAND researchers have accused the President of spreading misinformation that “undermines the United States’ credibility with its allies.”

• Brookings Institution: Arnold has provided $5.7 million in funding since 2020
  • Brookings scholars accused the Trump Administration of “weaponizing federal civil rights enforcement to promote discrimination.”
  •  The think tank claimed the administration has engaged in “an unprecedented effort to repurpose federal anti-discrimination law to reverse longstanding efforts to promote equality in public life.”

• Brookings contradicted itself on education policy, first criticizing Trump for ignoring poor NAEP scores, then defending those same scores when the President cited them as justification for closing the Department of Education.

• Center for American Progress: Arnold has provided $1.5 million in funding since 2020
  • CAP, led by former Biden Administration official Neera Tanden, has published articles claiming Trump “brings Chinese-style authoritarianism to America.”
  • The organization stated that the “Trump administration is learning the worst lessons from Beijing—lessons about the use of state power for extortion, the demand for absolute fealty, and the control of information and ideas.”
  • CAP maintains a tracker called “Trump’s Take” to document alleged corruption by the President and his family, claiming it tracks “the cash and gifts that President Donald Trump and his family have received by selling the presidency.”

Read the full report here.

Arnold Ventures was founded by billionaires Laura and John Arnold, who have cultivated an image of bipartisanship, particularly in healthcare policy. The Laura and John Arnold Foundation serves as the philanthropic arm of Arnold Ventures and commands $4.77 billion in assets with approximately $200 million in annual spending. Despite publicly emphasizing bipartisan collaboration, Arnold Ventures has directed substantial funding to organizations that have made opposing President Trump a central focus of their advocacy and research. 

The Institute for Health Policy Accountability is an independent authority on key drivers of decision making in the health care space. IHPA provides fact-based research and analysis across the public policy landscape, adding a central and currently missing voice to the conversation.

###

The post IHPA Report Finds Self-Proclaimed “Bipartisan” Arnold Ventures Secretly Bankrolls Organizations That Steadfastly Oppose President Trump appeared first on Institute for Health Policy Accountability.

This report comes as a bill (HB2371 SA2) moves through the Illinois Legislature to expand the 340B program. It is the latest study in IHPA’s ongoing series examining how non-profit hospitals nationwide are leaving low-income patients behind while misusing and profiting from the 340B program, a federal initiative intended to help hospitals provide care and affordable medications to underserved populations. The Illinois report reviews some of the state’s largest non-profit hospital systems that participate in the 340B program, including Northwestern Memorial Healthcare, Advocate Health and Hospitals Corporation, OSF Healthcare System, University of Chicago Medical Center, Rush University Medical Center, NorthShore University Health System, and Loyola University Medical Center.

Key findings from the IHPA New York report include:

Failure to serve low-income communities

• A statewide analysis found that 63 percent of Illinois’ private non-profit hospitals received more in tax benefits than they invested back into their communities, amounting to a $1.3 billion fair share deficit annually.
• Nine IL non-profit hospitals spent less than the state average on community investment, while four spent under 50 percent of the state average rate.

Lavish executive compensation and corporate excess

• Northwestern Memorial Healthcare paid over $23 million in total executive compensation in 2024, including more than $6 million to Executive Chairman Dean Harrison and $4.3 million to President and CEO Howard Chrisman.
• University of Chicago Medical Center’s president took home nearly $3.5 million in 2023, with seven other employees also clearing seven figures.
• Rush University Medical Center spent nearly $36 million on executive compensation in 2023, including over $3.5 million for its President and CEO.
• Advocate Health paid the president of its children’s hospital over $2.2 million in 2024, with 11 employees earning seven-figure salaries that same year.

Massive revenues and rapid financial growth

• Northwestern Memorial Healthcare reported more than $10 billion in revenue in 2024, growing nearly 10 percent year over year.
• Advocate Health and Hospitals Corporation generated nearly $7.8 billion in revenue, growing more than 13 percent year over year.
• OSF Healthcare System reported nearly $3.9 billion in revenue, growing 15.1 percent year over year.
• University of Chicago Medical Center, Rush University Medical Center, NorthShore University Health System, and Loyola University Medical Center each reported billions in annual revenue.

Fraud, abuse, and putting profits over patients

• NorthShore University Health System’s Evanston Hospital received $152 million more in tax breaks than it spent on community services between 2020 and 2022, the largest fair share deficit of any hospital in Illinois.
• Northwestern Memorial Hospital faced a whistleblower complaint in 2010 alleging the hospital and Northwestern University double-billed both Medicare and the National Institutes of Health (NIH) for the same patients, with the whistleblower alleging that employees who raised concerns faced retaliation.
• OSF Saint Francis Medical Center was ordered by a judge to pay $41 million in a medical malpractice case after a patient suffered a stroke and permanent brain damage due to the hospital’s failure to monitor his lab results.

Read the full report here.

BACKGROUND ON 340B: 

• The 340B Drug Pricing Program was enacted by Congress in 1992 and meant to lower prescription drug costs for non-profit hospitals that serve low-income and vulnerable communities. Instead, research shows the program has been exploited by major non-profit health systems that generate billions in annual revenue.
• This report follows a Senate HELP Committee hearing in October 2025, where Republican Senators voiced their frustrations with the program.
• According to a CBO analysis late last year, hospitals across the U.S. have exploited the 340B Drug Pricing Program, resulting in significant waste, fraud, and abuse. The report found that the program “encourages behaviors that increase federal spending and raise prices for American taxpayers.”

The Institute for Health Policy Accountability is an independent authority on key drivers of decision making in the health care space. IHPA provides fact-based research and analysis across the public policy landscape, adding a central and currently missing voice to the conversation.

###

The post IHPA Exposes IL Non-Profit Hospitals Exploiting Federal Program Designed for the Poor as Bill Seeking to Expand the Program Moves Through Statehouse appeared first on Institute for Health Policy Accountability.

This report is the latest in IHPA’s ongoing series examining how non-profit hospitals nationwide are leaving low-income patients behind while profiting from the 340B program, a federal initiative intended to help hospitals provide care and affordable medications to underserved populations. The New York report reviews some of the state’s largest non-profit hospital systems that participate in the 340B program, including NewYork-Presbyterian, NYU Langone Health, Montefiore Health System, Albany Medical Center, Northwell Health, Memorial Sloan Kettering Cancer Center, BronxCare Health System, and Mohawk Valley Health System. 

Key findings from the IHPA New York report include:

Failing to serve low-income communities

• A statewide analysis found that 42 percent of New York’s non-profit hospitals received more in tax benefits than they invested back into their communities, amounting to $518 million annually.
• NewYork-Presbyterian, NYU Langone, and Albany Medical Center each posted some of the largest “fair share deficits” in the state, meaning they took tens of millions more in taxpayer benefits than they invested in the community.

Lavish executive compensation and corporate excess

• NewYork-Presbyterian paid outgoing CEO Steven J. Corwin $23.3 million in 2024, with 25 executives earning more than $1 million annually.
• NYU Langone Health paid Dean and CEO Robert Grossman $15.3 million in 2024, while employing at least 13 executives with seven-figure salaries. 
• Memorial Sloan Kettering paid President and CEO Selwyn Vickers $6.6 million, and Albany Medical Center paid its CEO $5.8 million, despite both receiving substantial taxpayer benefits.

Massive revenues and rapid financial growth

• NewYork-Presbyterian reported more than $10.6 billion in revenue in 2024.
• NYU Langone generated $9.45 billion in revenue, growing more than 6 percent year over year.
• Montefiore Medical Center reported nearly $6 billion in revenue, with a growth rate approaching 17 percent.
• Albany Medical Center, Northwell Health, Memorial Sloan Kettering, BronxCare, and Mohawk Valley Health System all reported hundreds of millions to billions of dollars in annual revenue.

Fraud, abuse, and putting profits over patients

• New York-Presbyterian paid millions of dollars to settle allegations involving medically unnecessary procedures and illegal kickbacks.
• Northwell Health paid more than $25 million across multiple settlements related to billing for services not performed and medically unnecessary procedures.
• Montefiore Health System paid $4.75 million after failing to protect the health records of more than 12,500 patients, whose data was stolen and sold.
• Memorial Sloan Kettering faced extensive scrutiny after investigations revealed executives received undisclosed financial benefits tied to outside medical and pharmaceutical companies.

Read the full report here.

BACKGROUND ON 340B: 

• The 340B Drug Pricing Program was enacted by Congress in 1992 and meant to lower prescription drug costs for non-profit hospitals that serve low-income and vulnerable communities. Instead, research shows the program has been exploited by major non-profit health systems that generate billions in annual revenue.
• This report follows a Senate HELP Committee hearing in October 2025, where Republican Senators voiced their frustrations with the program.
• According to a CBO analysis late last year, hospitals across the U.S. have exploited the 340B Drug Pricing Program, resulting in significant waste, fraud, and abuse. The report found that the program “encourages behaviors that increase federal spending and raise prices for American taxpayers.”

The Institute for Health Policy Accountability is an independent authority on key drivers of decision making in the health care space. IHPA provides fact-based research and analysis across the public policy landscape, adding a central and currently missing voice to the conversation.

###

The post IHPA Finds New York Non-Profit Hospitals Amass Billions in Revenue While Profiting from Programs Meant for the Poor appeared first on Institute for Health Policy Accountability.

Evidence of the 340B profitability for major non-profit hospital systems is the program’s rapid rate of expansion into new health care settings in recent years. Since 2010, the Congressional Budget Office (CBO) reported a 19% annual increase in the program. Over that same period, the poverty rate in the United States has fallen significantly. By all rights, a program that was designed to help underserved communities and low-income patients should not be growing rapidly while poverty is declining. Clearly something is wrong and the system is being abused.

The Staggering One-Year Growth of 340B Program

Between 2023 and 2024, drug purchases under the 340B program grew by $15.1 billion, from $66.3 billion to $81.4 billion. Looking further into the estimated proportional share of each state’s 340B growth shows that purchases under the program were increasing in a dozen states by more than $1 million per day. In California alone, 340B purchases increased by more than $4.7 million per day in 2024.

The facts show that these purchases were not being expanded to keep up with the low-income population growth in states, but rather to maximize profits for non-profit hospitals. As a result, drug prices are going up, and the 340B program is covering people who were never intended to be a part of the system. Congress must take action and make reforms to this system immediately in order to help lower the cost of prescription drugs.

The table below demonstrates how fast the 340B system grew in each state in 2024. The data attributes an equal proportion of 340B purchase increases in the U.S. to that state’s proportion of the country’s population. Based on these estimates, many states across the country were expanding 340B program purchases by millions of dollars every day. The evidence makes it clear the 340B drug purchase growth is not directly correlated to the number of underserved individuals in a state as the program was intended.

The post 340B Program Grows by Over $1 Million Per Day in 12 States appeared first on Institute for Health Policy Accountability.